C-RAD AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002016352
SEK
31.25
-2.9 (-8.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About C-RAD AB stock-summary
stock-summary
C-RAD AB
Pharmaceuticals & Biotechnology
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Company Coordinates stock-summary
Company Details
Bredgrand 18 , UPPSALA None : 753 20
stock-summary
Tel: 46 18 666930
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lars Nyberg
Chairman of the Board
Mr. Per-Arne Blomquist
Director
Mr. Peter Hamberg
Director
Ms. Asa Hedin
Director
Mr. David Sjostrom
Director
Ms. Kicki Wallje-Lund
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Jun 2025)
Net Profit:
4 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,115 Million (Small Cap)

stock-summary
P/E

43.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.49

stock-summary
Return on Equity

6.55%

stock-summary
Price to Book

3.14